[6]-Gingerol
Based on 13 publication(s) in Google Scholar
[6]-Gingerol is an active compound isolated from Ginger (Zingiber officinale), exhibits a variety of biological activities including anticancer, anti-inflammation, and anti-oxidation.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 99.68%
- CAS. Nr.: 23513-14-6
- Formel: C17H26O4
- Molecular Weight:294.39
-
Speicherung:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 1 year , -20°C, 6 months
Publications Citing Use of MedChemExpress (MCE) [6]-Gingerol
More- Bioact Mater. 2024 Dec 10:46:82-96. [Abstract]
- Food Chem. 2024 Sep 15:452:139425. [Abstract]
- Phytomedicine. 2025 Jul:142:156713. [Abstract]
- Free Radic Biol Med. 2024 Feb 20:212:284-294. [Abstract]
- Arch Pharm Res. 2025 Dec;48(11-12):1460-1481. [Abstract]
- PLoS Biol. 2018 Jul 12;16(7):e2004921. [Abstract]
- J Ethnopharmacol. 2022 Mar 1:285:114786. [Abstract]
- Eur J Pharmacol. 2025 Sep 15:1003:177943. [Abstract]
- Microorganisms. 2026 Feb 26;14(3):539. [Abstract]
- ChemMedChem. 2025 Jan 23:e202400913. [Abstract]
- Appl Biochem Biotechnol. 2025 Mar 22. [Abstract]
- Kaohsiung J Med Sci. 2022 Apr;38(4):367-377. [Abstract]
- Cell Physiol Biochem. 2025 Dec 31;59(6):918-929. [Abstract]
-
Cell Proliferation/Viability Assay
-
Cell Imaging/Staining
-
WB
Alle AMPK Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
AMPK |
Apoptosis |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| DU-145 | IC50 |
95 mg/mL
Compound: Gingerol
|
Antiproliferative activity against human DU145 cells after 72 hrs by Alamar blue assay
Antiproliferative activity against human DU145 cells after 72 hrs by Alamar blue assay
|
[PMID: 31336310] |
| HeLa | IC50 |
636 mM
Compound: Gingerol
|
Cytotoxicity against human HeLa cells
Cytotoxicity against human HeLa cells
|
[PMID: 31336310] |
| KB | IC50 |
480 mM
Compound: Gingerol
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 31336310] |
| LNCaP | IC50 |
75 mg/mL
Compound: Gingerol
|
Antiproliferative activity against human LNCAP cells after 72 hrs by Alamar blue assay
Antiproliferative activity against human LNCAP cells after 72 hrs by Alamar blue assay
|
[PMID: 31336310] |
| LNCaP C4-2 | IC50 |
512 mg/mL
Compound: Gingerol
|
Antiproliferative activity against human C4-2 cells after 72 hrs by Alamar blue assay
Antiproliferative activity against human C4-2 cells after 72 hrs by Alamar blue assay
|
[PMID: 31336310] |
| LNCaP C4-2B | IC50 |
240 mg/mL
Compound: Gingerol
|
Antiproliferative activity against human C4-2B cells after 72 hrs by Alamar blue assay
Antiproliferative activity against human C4-2B cells after 72 hrs by Alamar blue assay
|
[PMID: 31336310] |
| NCI-H1299 | IC50 |
150 μM
Compound: [6]-gingerol
|
Cytotoxicity against human H1299 cells assessed as growth inhibition after 24 hrs by MTT assay
Cytotoxicity against human H1299 cells assessed as growth inhibition after 24 hrs by MTT assay
|
[PMID: 22246389] |
| PC-3 | IC50 |
250 mg/mL
Compound: Gingerol
|
Antiproliferative activity against human PC3 cells after 72 hrs by Alamar blue assay
Antiproliferative activity against human PC3 cells after 72 hrs by Alamar blue assay
|
[PMID: 31336310] |
| RBL-2H3 | IC50 |
185.1 μM
Compound: 5
|
Cytotoxicity against rat RBL2H3 cells after 12 hrs by MTT assay
Cytotoxicity against rat RBL2H3 cells after 12 hrs by MTT assay
|
[PMID: 19271742] |
| SCC-4 | IC50 |
500 mM
Compound: Gingerol
|
Cytotoxicity against human SCC4 cells
Cytotoxicity against human SCC4 cells
|
[PMID: 31336310] |
[6]-gingerol inhibits colon cancer cell proliferation and induced apoptosis, while the normal colon cells are unaffected. [6]-gingerol down-regulates phorbol myristate acetate induced phosphorylation of ERK1/2 and JNK MAP kinases and activation of AP-1 transcription factor, but has only little effects on phosphorylation of p38 MAP kinase and activation of NF-kappa B[1]. [6]-gingerol treatment is shown to restore impaired intestinal barrier function and to suppress proinflammatory responses in DSS-treated Caco-2 monolayers. AMPK is activated on [6]-gingerol treatment[2]. Treatment with [6]-gingerol results in a significant decrease in the viability of osteosarcoma cells in a dose-dependent fashion. In parallel, the number of cells arrested at the sub-G1 cell cycle phase is significantly increased. [6]-gingerol induces activation of caspase cascades and regulates cellular levels of Bcl2 and Bax[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 23513-14-6
-
Appearance Solid
-
Molecular Weight 294.39
-
Formel C17H26O4
-
Color White to off-white
-
SMILES
CCCCC[C@H](O)CC(CCC1=CC=C(O)C(OC)=C1)=O
-
Synonyms
(S)-(+)-[6]Gingerol
-
Structure Classification
-
Initial Source
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years 4°C 2 years In solvent -80°C 1 year -20°C 6 months
Publications (13)
-
Journal Impact Factor
-
Most Recent
-
Bioact Mater
Lipidomic analysis of plant-derived extracellular vesicles for guidance of potential anti-cancer therapy. [Abstract]2024 Dec 10:46:82-96. PMID: 39737211 -
Food Chem
2024 Sep 15:452:139425. PMID: 38744128 -
Phytomedicine
Bioactive equivalent combinatorial components of Xiao-Xu-Ming decoction inhibit the calmodulin-mediated MLCK/MLC axis to attenuate coronary artery spasm. [Abstract]2025 Jul:142:156713. PMID: 40349422 -
Free Radic Biol Med
SERCA2 dysfunction triggers hypertension by interrupting mitochondrial homeostasis and provoking oxidative stress. [Abstract]2024 Feb 20:212:284-294. PMID: 38163553 -
Arch Pharm Res
Cartilage extracellular matrix regeneration with 10-gingerol via KEAP1-NRF2-ARE axis for osteoarthritis therapy. [Abstract]2025 Dec;48(11-12):1460-1481. PMID: 41212495
[6]-Gingerol purchased from MedChemExpress. Usage Cited in: Arch Pharm Res. 2025 Dec;48(11-12):1460-1481. [Abstract]
Chondrocyte viability assessed by CCK-8 assay following treatment with [6]-Gingerol (0–100 μM).
[6]-Gingerol purchased from MedChemExpress. Usage Cited in: Arch Pharm Res. 2025 Dec;48(11-12):1460-1481. [Abstract]
A representative alricin blue staining image of glycosaminoglycans (GAGs) in chondrocytes after [6]-Gingerol treatment.
[6]-Gingerol purchased from MedChemExpress. Usage Cited in: Arch Pharm Res. 2025 Dec;48(11-12):1460-1481. [Abstract]
[6]-Gingerol treatment followed by Western blot analysis to detect the protein levels of PRG4 and COL2A1 in chondrocytes.
-
PLoS Biol
2018 Jul 12;16(7):e2004921. PMID: 30001322 -
J Ethnopharmacol
Exploring the pathogenesis of type 2 diabetes mellitus intestinal damp-heat syndrome and the therapeutic effect of Gegen Qinlian Decoction from the perspective of exosomal miRNA. [Abstract]2022 Mar 1:285:114786. PMID: 34763043 -
Eur J Pharmacol
2025 Sep 15:1003:177943. PMID: 40653078 -
Microorganisms
The Effect of Variations in Temperature and Contact Time of Zingerone, [6]-Gingerol and Shogaol as Disinfectants on Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Candida albicans. [Abstract]2026 Feb 26;14(3):539. PMID: 41900299 -
ChemMedChem
Machine Learning-Driven Discovery of Structurally Related Natural Products as Activators of the Cardiac Calcium Pump SERCA2a. [Abstract]2025 Jan 23:e202400913. PMID: 39853697 -
Appl Biochem Biotechnol
6-Gingerol Inhibits Ferroptosis in Endothelial Cells in Atherosclerosis by Activating the NRF2/HO-1 Pathway. [Abstract]2025 Mar 22. PMID: 40120045 -
Kaohsiung J Med Sci
Gingerol ameliorates neuronal damage induced by hypoxia-reoxygenation via the miR-210/brain-derived neurotrophic factor axis. [Abstract]2022 Apr;38(4):367-377. PMID: 34962339 -
Cell Physiol Biochem
2025 Dec 31;59(6):918-929. PMID: 41480969
Lösungsmittel & Löslichkeit
DMSO : 50 mg/mL (169.84 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (8.49 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (8.49 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 50% PEG300 50% Saline
Solubility: 25 mg/mL (84.92 mM); Clear solution; Need ultrasonic
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protokoll
[6]-gingerol stock (20 mg/mL) is prepared in ethanol and the working concentrations are prepared by diluting this stock in dimethyl sufoxide (DMSO). For MTT assay, 5×103 cells/well of human colon cancer cells and 104 cells/well of mouse IECs are seeded in 96-well plates. Cells are treated with [6]-gingerol for 48 h,72 h or 96 h before performing MTT assay and for 16 h before Annexin-V staining[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Mice: Mice with DSS-induced colitis are given different oral dosages of [6]-gingerol daily for 14 days. Body weight and colon inflammation are evaluated, and level of proinflammatory cytokines in colon tissues is measured[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Reinheit & Dokumentation
-
Data Sheet (275 KB)
-
SDS (480 KB)
- English - EN (480 KB)
- Français - FR (480 KB)
- Deutsch - DE (480 KB)
- Norwegian - NO (480 KB)
- Español - ES (480 KB)
- Swedish - SV (480 KB)
- Italian - IT (480 KB)
- Portuguese - PT (480 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Radhakrishnan EK, et al. [6]-Gingerol induces caspase-dependent apoptosis and prevents PMA-induced proliferation in colon cancer cells by inhibiting MAPK/AP-1 signaling. PLoS One. 2014 Aug 26;9(8):e104401. [Content Brief]
[2]. Chang KW, et al. 6-Gingerol modulates proinflammatory responses in dextran sodium sulfate (DSS)-treated Caco-2 cells and experimental colitis in mice through adenosine monophosphate-activated protein kinase (AMPK) activation. Food Funct. 2015 Oct;6(10):3334-41. [Content Brief]
[3]. Fan J, et al. 6-Gingerol inhibits osteosarcoma cell proliferation through apoptosis and AMPK activation. Tumour Biol. 2015 Feb;36(2):1135-41. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.3969 mL | 16.9843 mL | 33.9685 mL | 84.9214 mL |
| 5 mM | 0.6794 mL | 3.3969 mL | 6.7937 mL | 16.9843 mL | |
| 10 mM | 0.3397 mL | 1.6984 mL | 3.3969 mL | 8.4921 mL | |
| 15 mM | 0.2265 mL | 1.1323 mL | 2.2646 mL | 5.6614 mL | |
| 20 mM | 0.1698 mL | 0.8492 mL | 1.6984 mL | 4.2461 mL | |
| 25 mM | 0.1359 mL | 0.6794 mL | 1.3587 mL | 3.3969 mL | |
| 30 mM | 0.1132 mL | 0.5661 mL | 1.1323 mL | 2.8307 mL | |
| 40 mM | 0.0849 mL | 0.4246 mL | 0.8492 mL | 2.1230 mL | |
| 50 mM | 0.0679 mL | 0.3397 mL | 0.6794 mL | 1.6984 mL | |
| 60 mM | 0.0566 mL | 0.2831 mL | 0.5661 mL | 1.4154 mL | |
| 80 mM | 0.0425 mL | 0.2123 mL | 0.4246 mL | 1.0615 mL | |
| 100 mM | 0.0340 mL | 0.1698 mL | 0.3397 mL | 0.8492 mL |